Zobrazeno 1 - 10
of 241
pro vyhledávání: '"Maarten H. Vermeer"'
Autor:
Anne-Sophie C.A.M. Koning, MSc, PhD, Rosanne Ottevanger, MD, Maarten H. Vermeer, MD, PhD, Onno C. Meijer, MSc, PhD, Erik J. Giltay, MD, PhD
Publikováno v:
JAAD International, Vol 17, Iss , Pp 111-121 (2024)
Background: A substantial number of patients treated systemically with synthetic glucocorticoids undergo emotional disturbances during treatment. Patients with cutaneous T-cell lymphoma frequently experience skin inflammation and itching and often re
Externí odkaz:
https://doaj.org/article/412c38f401b84e0da31564122f9d16f3
Autor:
Rosanne Ottevanger, Esther Vermaas, Rein Willemze, Anne-Roos Schrader, Patty M. Jansen, Jelle J. Goeman, Hein Putter, Maarten H. Vermeer, Koen D. Quint
Publikováno v:
Acta Dermato-Venereologica, Vol 104 (2024)
The prognosis of patients with mycosis fungoides is variable. As the current literature is scarce and shows mixed results this study investigates the incidence of other primary malignancies in mycosis fungoides patients. A retrospective, nationwide,
Externí odkaz:
https://doaj.org/article/18e48b1ef4424bd58f911273db0bb379
Autor:
Roderick C. Slieker, Daniël O. Warmerdam, Maarten H. Vermeer, Remco van Doorn, Mirjam H. M. Heemskerk, Ferenc A. Scheeren
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract The Major Histocompatibility Complex class I (MHC-I) system plays a vital role in immune responses by presenting antigens to T cells. Allele specific technologies, including recombinant MHC-I technologies, have been extensively used in T cel
Externí odkaz:
https://doaj.org/article/db6bb0c4084a42c19c01bc85581e798a
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
This review systematically describes the application of in vivo mouse models in studying cutaneous T-cell lymphoma (CTCL), a complex hematological neoplasm. It highlights the diverse research approaches essential for understanding CTCL’s intricate
Externí odkaz:
https://doaj.org/article/eea5fb9e54a5464b902ec87f18c9ab23
Autor:
Celine M. Schreidah, BS, George Bingham Reynolds, MS, Lauren M. Fahmy, BS, Richard D. Carvajal, MD, Maarten H. Vermeer, MD, Sean Whittaker, MD, Itsik Pe’er, PhD, Larisa J. Geskin, MD
Publikováno v:
JAAD International, Vol 12, Iss , Pp 24-31 (2023)
Externí odkaz:
https://doaj.org/article/c29058b159354fdd87c91ab23cefb753
Autor:
Rosanne Ottevanger, Judith S. Feenstra, Liesbeth M. vanVliet, Sylvia vanBeugen, Andrea W. M. Evers, Cees Kennedy, Rein Willemze, Maarten H. Vermeer, Koen D. Quint
Publikováno v:
Skin Health and Disease, Vol 3, Iss 6, Pp n/a-n/a (2023)
Abstract Erythrodermic mycosis fungoides and Sézary syndrome are chronic, relapsing‐remitting diseases that greatly impacts patients' quality of life (QoL). Mogamulizumab‐kpkc (Mogamulizumab) is a novel therapeutic agent for cutaneous T‐cell l
Externí odkaz:
https://doaj.org/article/f6a5358fb7c94099a47f6572a42ae63e
Autor:
Rosanne Ottevanger, Sylvia van Beugen, Juliette M. Kersten, Andrea W. M. Evers, Maarten H. Vermeer, Rein Willemze, Koen D. Quint
Publikováno v:
Cancers, Vol 16, Iss 5, p 937 (2024)
Background: Little is known about the impact of MF on quality of life (QoL) in newly diagnosed patients. Objectives: To describe the impact of the MF diagnosis on QoL, patient expectations, and treatment satisfaction over the first 6 months after dia
Externí odkaz:
https://doaj.org/article/276f022e07114c318388601604a504c6
Publikováno v:
Acta Dermato-Venereologica, Vol 103 (2023)
Mycosis fungoides and Sézary syndrome are rare and largely incurable types of cutaneous T-cell lymphoma with limited therapeutic options. In 1984 Bunn et al. reported that interferon alpha is an efficient monotherapy in cutaneous T-cell lymphoma and
Externí odkaz:
https://doaj.org/article/6cb814485e674fa2a49a3720199f8ac0
Autor:
Yixin Luo, Maarten H. Vermeer, Sanne de Haan, Priscilla Kinderman, Frank R. de Gruijl, Thorbald van Hall, Cornelis P. Tensen
Publikováno v:
Biochemistry and Biophysics Reports, Vol 35, Iss , Pp 101535- (2023)
Recent detailed genomic analysis of mycosis fungoides (MF) identified suppressor of cytokine signaling 1 (SOCS1), an inhibitor of JAK/STAT signaling, as one of the frequently deleted tumor suppressors in MF, and one-copy deletion of SOCS1 was confirm
Externí odkaz:
https://doaj.org/article/b9355e1eca9f464bb2d0eb5d5e974c60
Autor:
Rosanne Ottevanger, MD, Sylvia van Beugen, MSc, PhD, Andrea W.M. Evers, MSc, PhD, Rein Willemze, MD, PhD, Maarten H. Vermeer, MD, PhD, Koen D. Quint, MD, PhD
Publikováno v:
JAAD International, Vol 9, Iss , Pp 57-64 (2022)
Background: Cutaneous T-cell lymphoma (CTCL) is a chronic and progressive disease that has a major impact on quality of life (QoL). Objectives: To describe the impact of the different stages of disease in patients with classical mycosis fungoides, fo
Externí odkaz:
https://doaj.org/article/8ed450d5e5dd442eb3f66be8015919df